Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses

INTRODUCTION: Phosphodiesterase-type 5 inhibitors (PDE5i) are the recommended first-line treatment for erectile dysfunction. Previous systematic reviews and meta-analyses suggest that they are a safe and effective option in many patient groups. Similarly, PDE5i may be effective as part of combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyrgidis, Nikolaos, Mykoniatis, Ioannis, Haidich, Anna-Bettina, Tirta, Maria, Talimtzi, Persefoni, Kalyvianakis, Dimitrios, Ouranidis, Andreas, Hatzichristou, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386228/
https://www.ncbi.nlm.nih.gov/pubmed/34429310
http://dx.doi.org/10.1136/bmjopen-2020-047396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386228/
https://www.ncbi.nlm.nih.gov/pubmed/34429310
http://dx.doi.org/10.1136/bmjopen-2020-047396

Ejemplares similares